Table 1.
Comparison of responses with respect to surgeons' geographic location (ie. continent) and performing ALPPS for non-colorectal liver metastases, performing anatomical variations of ALPPS, or recommending neoadjuvant chemotherapy prior to performing ALPPS for CRLM
| Europe | North America | South America | Asia and other | p-value | |
|---|---|---|---|---|---|
| ALPPS for non-CRLM, n (%) | 29 (81) | 4 (100) | 3 (60) | 11 (100) | 0.06 |
| Anatomical variation of ALPPS, n (%) | 25 (69) | 2 (50) | 3 (60) | 8 (73) | 0.82 |
| Neoadjuvant chemotherapy, n (%) | 23 (64) | 2 (50) | 4 (80) | 8 (73) | 0.76 |